Nothing Special   »   [go: up one dir, main page]

DE69430416D1 - Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen - Google Patents

Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen

Info

Publication number
DE69430416D1
DE69430416D1 DE69430416T DE69430416T DE69430416D1 DE 69430416 D1 DE69430416 D1 DE 69430416D1 DE 69430416 T DE69430416 T DE 69430416T DE 69430416 T DE69430416 T DE 69430416T DE 69430416 D1 DE69430416 D1 DE 69430416D1
Authority
DE
Germany
Prior art keywords
cysteine
amino acid
proportion
infections
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69430416T
Other languages
English (en)
Other versions
DE69430416T3 (de
DE69430416T2 (de
Inventor
Maurice Arnal
Francis Rose
Denis Breuille
Christiane Obled
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Institut National de la Recherche Agronomique INRA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9452315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69430416(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Nestle SA, Institut National de la Recherche Agronomique INRA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of DE69430416D1 publication Critical patent/DE69430416D1/de
Publication of DE69430416T2 publication Critical patent/DE69430416T2/de
Publication of DE69430416T3 publication Critical patent/DE69430416T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69430416T 1993-10-28 1994-10-27 Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen Expired - Lifetime DE69430416T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9312884A FR2711529B1 (fr) 1993-10-28 1993-10-28 Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
FR9312884 1993-10-28

Publications (3)

Publication Number Publication Date
DE69430416D1 true DE69430416D1 (de) 2002-05-23
DE69430416T2 DE69430416T2 (de) 2002-12-05
DE69430416T3 DE69430416T3 (de) 2009-01-22

Family

ID=9452315

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69430416T Expired - Lifetime DE69430416T3 (de) 1993-10-28 1994-10-27 Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen

Country Status (9)

Country Link
EP (1) EP0655244B2 (de)
KR (1) KR950010884A (de)
AT (1) ATE216234T1 (de)
CA (1) CA2134380C (de)
DE (1) DE69430416T3 (de)
DK (1) DK0655244T5 (de)
ES (1) ES2171439T5 (de)
FR (1) FR2711529B1 (de)
PT (1) PT655244E (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999038507A1 (en) * 1998-01-30 1999-08-05 David George Le Couteur Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
AU784137B2 (en) * 2000-02-04 2006-02-09 Societe Des Produits Nestle S.A. A method for maintaining or improving the synthesis of mucins
EP1302115A1 (de) * 2001-10-16 2003-04-16 Societe Des Produits Nestle S.A. Verwendung von Cystathionin
WO2005077400A1 (en) * 2004-02-12 2005-08-25 Campina Nederland Holding B.V. Cysteine rich peptides for improving thiol homeostasis
CA2620313C (en) * 2005-06-14 2011-08-02 Nestec S.A. Nutritional method for elderly people
DE102006018293A1 (de) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
EP2165713B1 (de) 2008-09-19 2012-11-14 Nestec S.A. Molke und Verbesserung der Thymusfunktion
WO2011021926A1 (en) 2009-08-21 2011-02-24 N.V. Nutricia Regulating the amino acid pool used for the acute-phase protein synthesis
EP2444083A1 (de) 2010-10-21 2012-04-25 Nestec S.A. Cystein- und Nahrungsmittelaufnahme
WO2024122796A1 (ko) * 2022-12-05 2024-06-13 의료법인 성광의료재단 아스파르트산을 유효성분으로 포함하는 패혈증의 예방 또는 치료용 약학적 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2531204C2 (de) * 1975-07-12 1987-01-22 Fresenius AG, 6380 Bad Homburg L-Aminosäuregemische für die parenterale oder orale Ernährung
DE2946563C2 (de) * 1979-11-17 1987-04-30 B. Braun Melsungen Ag, 3508 Melsungen Aminosäurelösung zur parenteralen Infusion
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4604286A (en) * 1984-09-17 1986-08-05 Daigo Nutritive Chemicals, Ltd. Infusion solution for parenteral nutrition
AU605214B2 (en) * 1986-10-24 1991-01-10 Fresenius Kabi Ab N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
SE8704217D0 (sv) * 1987-10-29 1987-10-29 Vinnars Erik Ab Aminosyrakomposition for parenteral neringstillforsel
US5224409A (en) † 1991-03-19 1993-07-06 Ashlock Company Apparatus for producing helical slices
US5214062A (en) † 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
AU6060694A (en) † 1993-05-10 1994-11-17 Transcend Therapeutics, Inc Method for treating acquired immune deficiency syndrome

Also Published As

Publication number Publication date
DK0655244T3 (da) 2002-08-05
ATE216234T1 (de) 2002-05-15
FR2711529A1 (fr) 1995-05-05
EP0655244B2 (de) 2008-06-11
DK0655244T5 (da) 2008-10-13
ES2171439T5 (es) 2008-12-01
DE69430416T3 (de) 2009-01-22
KR950010884A (ko) 1995-05-15
CA2134380C (en) 2010-06-22
DE69430416T2 (de) 2002-12-05
PT655244E (pt) 2002-08-30
EP0655244A1 (de) 1995-05-31
CA2134380A1 (en) 1995-04-29
FR2711529B1 (fr) 1996-07-05
EP0655244B1 (de) 2002-04-17
ES2171439T3 (es) 2002-09-16

Similar Documents

Publication Publication Date Title
DE69305105D1 (de) Zusammensetzungen zur oralen Nahrungsmittelaufnahme mit verbessertem Geschmack
DE69429297D1 (de) Zusammensetzung zur Behandlung von Patienten mit Lebererkrankungen
ES2163444T3 (es) Composiciones y metodos para la administracion oral de farmacos.
ATE165100T1 (de) Peptide mit endothelin antagonistischer aktivität, deren herstellung und pharmazeutische zusammensetzungen
ES2141229T3 (es) Productos farmaceuticos de proteinas y peptidos modificados.
ATE213499T1 (de) Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
DE59810596D1 (de) Humanes, rekombinantes interferon-beta mit verbesserter löslichkeit
DE69430416D1 (de) Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
CA2334941A1 (en) Tnf-derived peptides for use in treating oedema
AU7683296A (en) Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them
DE3866045D1 (de) Arzneimittel zur behandlung von uraemie.
WO2002058589A3 (en) Agents and methods for promoting bone growth
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
ATE272399T1 (de) Zusammensetzungen aus aminosäuren zur behandlung von herzinsuffizienz
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
ATE233105T1 (de) Pharmazeutische zubereitung für die intravenöse oder intramuskuläre verabreichung von octreotid
HK1031664A1 (en) Use of an organ-specific nutritional composition
WO1998001474A3 (en) Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth
KR920700224A (ko) 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제
DE60040856D1 (de) Lactalbumin zur kurativen Behandlung von Magengeschwüren
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: SOCIETE DES PRODUITS NESTLE S.A., VEVEY, CH

Owner name: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE , FR